All Articles

The abstract submission portal is open, and our expert peer-reviewers are standing by, awaiting your evidence-based navigation research studies, quality improvement projects, and best practices to consider for inclusion at the AONN+ Annual Conference.

Little is known about the role of community-based navigation in supportive care delivery for historically marginalized cancer survivors. The purposes of this study were to evaluate supportive care experiences of low-income Black and Latina cancer survivors and examine the care role of their community navigator.

Cancer care is extremely complex, and a truly holistic approach to quality care goes beyond radiation, chemotherapy, and surgery, according to Pamela Goetz, BA, OPN-CG, survivorship program manager at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington, DC.

A recent study demonstrates liquid biopsy has high concordance to tissue biopsy in non–small-cell lung cancer, making it an acceptable first-line testing option.

A small study of patients with non–small-cell lung cancer with brain metastasis showed sotorasib had promising efficacy on brain lesions.

A recent retrospective analysis of patients with non–small-cell lung cancer harboring KRAS mutations found immune checkpoint inhibitors have benefit in first- and second-line treatment among KRAS subtypes.

A large retrospective chart review found a short median progression-free survival in patients with non–small-cell lung cancer harboring the KRAS G12C mutation who were treated with docetaxel with or without ramucirumab.

Prisma Health Cancer Institute

Biomarker testing is associated with improved overall survival in patients with advanced non–small-cell lung cancer, but disparities in access to testing persist.